Skip to main content
All lobbying filings

G2G CONSULTING

Lobbying for VOLTRON THERAPEUTICS · vaccine development

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · posted Apr 16, 2026

Official filing document

 Lobbying activity 1
Health Issues

educating and advancing platform vaccine development; cancer

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem